Artelo Biosciences Inc
Veridion Score
Composite trend over time
Why is ARTL moving today?
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ARTL.
ARTL insider activity
Artelo Biosciences Inc
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for ARTL.
ARTL contract awards, year to date.
Public federal awards linked to this ticker.
ARTL lobbying filings, year to date.
Registered lobbying filings matched to Artelo Biosciences Inc.